DermaRite Industries Issues Expanded Recall for Affected Products

Recall Announcement from DermaRite Industries

DermaRite Industries, LLC, known for its commitment to quality and safety in healthcare products, is expanding its voluntary recall of certain items due to potential microbial contamination. This expansion is a precautionary measure taken in response to the discovery of Burkholderia cepacia complex in specific product lots.

Understanding the Risks

Burkholderia cepacia may pose serious health risks, particularly for immunocompromised individuals. If these products are used on such individuals, they may be at an increased risk for severe infections. Even healthy individuals could face complications, such as local infections, especially if they have minor skin lesions. There is a risk that the infection could escalate to severe conditions, including sepsis, if not managed correctly.

Details of the Affected Products

The recall encompasses multiple products intended for a variety of skin care and sanitizing purposes. Here is a list of some of the products affected:

4-N-1 Wash Cream: A no-rinse product designed to temporarily protect and relieve chafed or cracked skin.

DermaCerin: This moisturizing cream protects dry or cracked skin and is also effective against the drying effects of wind and weather.

DermaFungal: An antifungal formulation for combating athlete's foot and jock itch, it helps alleviate itching and discomfort associated with these conditions.

DermaKleen: An antiseptic lotion soap for handwashing, fortified with Vitamin E, designed to reduce bacteria on the skin.

Hand E Foam: A foaming hand sanitizer made for repeated use, also containing Vitamin E for skin health.

Lantiseptic: Specialized for minor cuts and scrapes, this skin protectant is designed to shield against further irritation.

These products were distributed widely across the United States and can be found in various healthcare facilities.

Steps for Consumers

In light of this situation, DermaRite has taken steps to notify distributors and customers about the recall. Consumers must check their inventories, and if they discover any of the listed products, they should immediately dispose of them following the facility's protocols. It is advised that consumers experiencing issues related to these products consult their healthcare providers for appropriate advice.

How to Report Issues

Consumers who have encountered adverse effects or health issues associated with these products are encouraged to report these experiences. The FDA's MedWatch program allows for easy reporting of any concerning reactions or product quality issues. Reports can be made online or through traditional mail methods.

Ongoing Compliance and Safety Assurance

DermaRite is committed to maintaining safety standards and protecting the health of its consumers. The company is addressing this recall with diligence and transparency, working closely with public health officials.

Frequently Asked Questions

What triggered the recall of these products?

The recall was initiated due to the potential contamination with Burkholderia cepacia, which poses serious health risks, especially for immunocompromised individuals.

What actions should consumers take if they have these products?

Consumers should immediately check their inventory for affected products and dispose of them according to their healthcare facility's disposal protocols.

Where can I find a list of affected products?

The list of affected products is available via official communications from DermaRite Industries, including detailed descriptions.

Who can I contact for further questions regarding this recall?

Consumers can reach out to customer support at DermaRite for further information and guidance related to the recall.

Are the recalled products safe to use until further notice?

No, it is advised not to use any of the recalled products to avoid potential health risks.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.